Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8377688 Use of MVA to treat prostate cancer

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
August 30, 2010
0
Date of Patent
February 19, 2013
0
Patent Application Number
12871017
0
Patent Citations Received
‌
US Patent 12018289 Vaccines based on mutant CALR and JAK2 and their uses
0
‌
US Patent 11884939 Vaccinia virus mutants useful for cancer immunotherapy
0
‌
US Patent 11986503 Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy
0
Patent Inventor Names
Alain Delcayre
0
Fatema Legrand
0
Reiner Laus
0
Ryan Blair Rountree
0
Stefanie Mandl
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8377688
0
Patent Primary Examiner
‌
Bao Li
0

Find more entities like US Patent 8377688 Use of MVA to treat prostate cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo